commercialization of therapeutics

Annexon Biosciences is a clinical-stage biopharmaceutical company focused on stopping C1q, the initiating molecule of the classical complement pathway, to treat autoimmune, neurodegenerative, and ophthalmic diseases of the body, brain and eye. It was co-founded by Dr. Ben Barres and Dr. Arnon Rosenthal and has a late-stage clinical pipeline of therapies targeting complement-mediated diseases.

Read more

clinical trialstherapeutics discovery and development

Genoplexus is a team of life science professionals with decades of operational and commercial experience in a broad range of therapeutic areas. Their mission is to discover, develop and commercialize therapeutics that improve the lives of patients living with devastating diseases, transforming ideas into reality.

Read more

therapeutic developmenttherapeutic discovery